ImmunoGen, Inc. (IMGN) Social Stream



ImmunoGen, Inc. (IMGN): $14.77

0.16 (-1.07%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add IMGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#68 of 359

in industry

IMMUNOGEN INC (IMGN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMGN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 7 $12 $5 $7.9 $14.93 -47.09%
2021-12-01 7 $12 $5 $8.9 $14.93 -40.39%
2022-02-02 7 $12 $6.5 $9.3 $14.93 -37.71%
2022-02-11 8 $18 $6.5 $10.75 $14.93 -28%
2022-03-09 8 $18 $5 $10.416 $14.93 -30.23%
2022-03-20 9 $18 $5 $10.416 $14.93 -30.23%
2022-03-21 9 $18 $5 $9.642 $14.93 -35.42%
2022-05-06 9 $18 $5 $9.571 $14.93 -35.89%
2022-08-01 9 $18 $4 $9.666 $14.93 -35.26%
2022-08-10 9 $18 $4 $9.428 $14.93 -36.85%
2022-08-31 9 $18 $4 $9.285 $14.93 -37.81%
2022-09-09 9 $18 $4 $9.125 $14.93 -38.88%
2022-11-07 10 $18 $4 $9.125 $14.93 -38.88%
2022-11-15 10 $18 $4 $9.25 $14.93 -38.04%
2022-11-16 11 $20 $4 $11 $14.93 -26.32%
2022-11-28 12 $20 $4 $10.9 $14.93 -26.99%
2023-01-05 12 $19.001 $4 $10.4 $14.93 -30.34%
2023-02-27 12 $19.001 $4 $10.5 $14.93 -29.67%
2023-03-02 12 $19.001 $3 $10.4 $14.93 -30.34%
2023-04-28 11 $19.001 $3 $10.889 $14.93 -27.07%
2023-05-01 11 $19.001 $3 $11 $14.93 -26.32%
2023-05-03 11 $19.001 $5 $13.222 $14.93 -11.44%
2023-05-09 11 $19.001 $8 $13.555 $14.93 -9.21%
2023-06-05 11 $19.001 $8 $13.889 $14.93 -6.97%
2023-06-06 11 $19.001 $8 $14.333 $14.93 -4%
2023-06-13 11 $21 $8 $16.222 $14.93 8.65%
2023-06-16 11 $24 $8 $17.111 $14.93 14.61%
2023-07-18 11 $24 $8 $18 $14.93 20.56%
2023-07-27 11 $24 $8 $18.444 $14.93 23.54%
2023-08-01 11 $24 $8 $19 $14.93 27.26%
2023-08-02 11 $27 $9.001 $22 $14.93 47.35%
2023-08-29 11 $27 $9.001 $22.111 $14.93 48.1%
2023-09-13 11 $27 $13 $23.555 $14.93 57.77%

The Trend in the Analyst Price Target


IMGN's average price target has moved up $14.25 over the prior 22 months.

IMGN reports an average of 75.4% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-15 10 18.000 4.000 9.250 5.01 84.63%
2023-01-23 12 19.001 4.000 10.500 4.66 125.32%
2023-03-02 12 19.001 3.000 10.889 4.45 144.7%
2023-05-09 11 19.001 8.000 13.555 13.75 -1.42%
2023-08-02 11 27.000 9.001 22.000 17.17 28.13%

IMGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.18 10 0 1 0 0 11

The Trend in the Broker Recommendations


IMGN's average broker recommendation rating improved by 0.62 over the prior 52 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, IMMUNOGEN INC's upside potential (average analyst target price relative to current price) is greater than 495.23% of them.
  • IMGN has a lower variance in analysts' estimates than -3165.75% of all US stocks.
  • IMMUNOGEN INC's average analyst price target is greater than 556.5% of stocks in the mid market cap category.
  • In the context of stocks in the mid market cap category, IMMUNOGEN INC's number of analysts covering the stock is greater than 2711.25% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IMMUNOGEN INC are HRTX, ADCT, and ROIV.

Make investment decisions regarding IMGN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!